|
Press Releases |
|
|
|
Wednesday, June 9, 2021 |
|
エーザイ、第3回「プラチナキャリア・アワード」において特別賞を受賞 |
エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫)は、このたび、第3回「プラチナキャリア・アワード」において、特別賞を受賞しましたのでお知らせします。表彰式は2021年6月8日にオンラインのシンポジウムにて行われました。 more info >> |
|
Eisai Receives Special Prize at Platinum Career Award 2021 |
Eisai Co., Ltd. announced today that it has received a special prize at the Platinum Career Award 2021. The awards ceremony was held via online at the symposium on June 8, 2021. more info >> |
|
エーザイ、レンボレキサントの最新データを第35回米国睡眠学会年次総会において発表 |
more info >> |
|
Eisai To Present Latest Data of Lemborexant at 35th Annual Sleep Meeting (SLEEP2021) |
Eisai Co., Ltd. announced today that a total of 5 poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO) will be given at the 35th annual meeting of the Associated Professional Sleep Societies (SLEEP 2021), to be held virtually from June 10 to 13, 2021. more info >> |
|
Tuesday, June 8, 2021 |
|
Biogen and Eisai launch initiatives to help patients with Alzheimer's disease access ADUHELM |
Following U.S. Food and Drug Administration's (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as the first and only Alzheimer's disease treatment to address a defining pathology of the diseas. more info >> |
|
バイオジェンとエーザイ、ADUHELM(TM)についてアルツハイマー病の病理に作用する初めてかつ唯一の治療薬として米国FDAより迅速承認を取得 |
バイオジェン(Nasdaq: BIIB、CEO:ミシェル・ヴォナッソス、以下 バイオジェン)とエーザイ株式会社(代表執行役CEO:内藤晴夫、以下 エーザイ)は、本日、米国食品医薬品局(FDA)がADUHELM(TM)(一般名:アデュカヌマブ)について、脳内のアミロイドβプラークを減少させることにより、アルツハイマー病(AD)の病理に作用する初めてかつ唯一のAD治療薬として、迅速承認したことをお知らせします。 more info >> |
|
FDA grants accelerated approval for ADUHELM as the first and only Alzheimer's disease treatment to address a defining pathology of the disease |
Biogen and Eisai, Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM (aducanumab-avwa) as the first and only Alzheimer's disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain. more info >> |
|
Eisai: New Data on LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus Sunitinib |
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. announced new investigational data from the pivotal Phase 3 CLEAR(Study 307)/KEYNOTE-581 trial, which evaluated the combinations of LENVIMA. more info >> |
|
Wednesday, June 2, 2021 |
|
エーザイ、人事異動(2021年6月1日付)を発表 |
エーザイ株式会社は本日、人事異動(2021年6月1日付)を発表しました。 more info >> |
|
Monday, May 31, 2021 |
|
Eisai and ITO EN Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia |
Eisai Co., Ltd. and ITO EN, LTD. announced today that both parties have entered into a business alliance agreement concerning the initiatives for supporting people living with and preventing dementia with the aim of realizing a healthy and long-lived society. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
Apr 30, 2024 19:40 HKT/SGT
|
|
|
Q2 Metals Announces Completion of Drill-Core Re-Evaluation for the Cisco Lithium Property, James Bay Territory, Quebec, Canada
Apr 30, 2024 19:09 HKT/SGT
|
|
|
Hong Kong Gifts, printing and packaging, and licensing events foster cross-industry opportunities
Apr 30, 2024 19:00: JST
|
|
|
DCCI fortifies stance for Malaysia's greatest show: Wins support from key government organisations
Apr 30, 2024 18:56: JST
|
|
|
Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
Apr 30, 2024 19:08 JST
|
|
|
Hong Kong Gifts, printing and packaging, and licensing events foster cross-industry opportunities
Apr 30, 2024 18:00 HKT/SGT
|
|
|
Moolec Announces New Patent Granting in the United States for Molecular Farming Platform
Apr 30, 2024 18:00 HKT/SGT
|
|
|
DCCI fortifies stance for Malaysia's greatest show: Wins support from key government organisations
Apr 30, 2024 17:56 HKT/SGT
|
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Apr 30, 2024 17:00 HKT/SGT
|
|
|
住友金属鉱山と三菱商事、豪州カルグーリー・ニッケル・プロジェクト グーンガリー・ハブの事業化調査・新規参画について
Apr 30, 2024 17:00: JST
|
|
|
Wintermar Offshore (WINS:JK) Reports 1Q2024 Results
Apr 30, 2024 16:48 HKT/SGT
|
|
|
Q&M Dental Enhances its Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore
Apr 30, 2024 16:25 HKT/SGT
|
|
|
SMEStreet Celebrates 10 Years of Serving Indian MSMEs
Apr 30, 2024 16:23 HKT/SGT
|
|
|
Rockbird media Presents HR Leaders & HR Tech Strategy Meeting 2024: 'Rehumanizing Work with Emerging Technologies' in Manila
Apr 30, 2024 16:20 HKT/SGT
|
|
|
Tex Cycle Partners with Evolusi Bersatu to Launch Sabah's First Integrated Scheduled Waste Management Facility
Apr 30, 2024 15:55 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|